Antimalarials and electrocardiographic alterations: New data bring confidence
Written By : Dr. Kamal Kant Kohli
Published On 2022-06-05 14:30 GMT | Update On 2022-06-05 14:31 GMT
Advertisement
Previous findings on the link between hydroxychloroquine and risk of arrhythmia have been contradictory, with low-level evidence-based results. To address this, Md Rashedul Hoque and colleagues in Arthritis Research Canada and Simon Fraser University ran a large cohort study. The group identified 11,518 hydroxychloroquine initiators with newly diagnosed with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE), and assessed the risk of incident arrhythmia. The results were presented at the 2022 EULAR Congress in Copenhagen.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.